TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
128,699
|
105,542
|
108,071 |
| Financial expenses |
1,616
|
1,568
|
2,092 |
| Earnings before taxes |
8,673
|
1,252
|
2,971 |
| Total assets |
83,200
|
72,602
|
80,528 |
| Current assets |
44,723
|
27,543
|
32,183 |
| Current liabilities |
34,510
|
27,373
|
29,598 |
| Equity capital |
30,503
|
24,817
|
25,334 |
| - share capital |
225
|
237
|
253 |
| Employees (average) |
88
|
86 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.7%
|
34.2%
|
31.5% |
| Turnover per employee |
1,462
|
1,227 | |
| Profit as a percentage of turnover |
6.7%
|
1.2%
|
2.7% |
| Return on assets (ROA) |
12.4%
|
3.9%
|
6.3% |
| Current ratio |
129.6%
|
100.6%
|
108.7% |
| Return on equity (ROE) |
28.4%
|
5.0%
|
11.7% |
| Change turnover |
28,456
|
4,111
|
-14,456 |
| Change turnover % |
28%
|
4%
|
-12% |
| Chg. No. of employees | 2 | ||
| Chg. No. of employees % | 2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.